Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among late-stage ovarian cancer patients on PARP inhibitors
Research Grant
Administered By
Obstetrics and Gynecology
Awarded By
Dana-Farber Cancer Institute
Start Date
June 1, 2024
End Date
May 31, 2029
Administered By
Obstetrics and Gynecology
Awarded By
Dana-Farber Cancer Institute
Start Date
June 1, 2024
End Date
May 31, 2029